| Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus W Li, MJ Moore, N Vasilieva, J Sui, SK Wong, MA Berne, ... Nature 426 (6965), 450-454, 2003 | 7354 | 2003 |
| Changes in thymic function with age and during the treatment of HIV infection DC Douek, RD McFarland, PH Keiser, EA Gage, JM Massey, BF Haynes, ... Nature 396 (6712), 690-695, 1998 | 2343 | 1998 |
| Severe herpesvirus infections in an adolescent without natural killer cells CA Biron, KS Byron, JL Sullivan New England Journal of Medicine 320 (26), 1731-1735, 1989 | 1651 | 1989 |
| HLA B* 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors SA Migueles, MS Sabbaghian, WL Shupert, MP Bettinotti, FM Marincola, ... Proceedings of the National Academy of Sciences 97 (6), 2709-2714, 2000 | 1324 | 2000 |
| Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection F Kirchhoff, TC Greenough, DB Brettler, JL Sullivan, RC Desrosiers New England Journal of Medicine 332 (4), 228-232, 1995 | 1319 | 1995 |
| Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant RS Sperling, DE Shapiro, RW Coombs, JA Todd, SA Herman, ... New England Journal of Medicine 335 (22), 1621-1629, 1996 | 1076 | 1996 |
| Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. VJ Merluzzi, KD Hargrave, M Labadia, K Grozinger, M Skoog, JC Wu, ... Science (New York, NY) 250 (4986), 1411, 1990 | 1045 | 1990 |
| Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States A Kwan, RS Abraham, R Currier, A Brower, K Andruszewski, JK Abbott, ... Jama 312 (7), 729-738, 2014 | 764 | 2014 |
| Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy DD Richman, D Havlir, J Corbeil, D Looney, C Ignacio, SA Spector, ... Journal of virology 68 (3), 1660-1666, 1994 | 754 | 1994 |
| Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1 SL Gortmaker, M Hughes, J Cervia, M Brady, GM Johnson, GR Seage III, ... New England Journal of Medicine 345 (21), 1522-1528, 2001 | 580 | 2001 |
| Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus DW Hanto, G Frizzera, DT Purtilo, K Sakamoto, JL Sullivan, ... Cancer research 41 (11_Part_1), 4253-4261, 1981 | 571 | 1981 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 569 | 2008 |
| Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy ME Sharkey, I Teo, T Greenough, N Sharova, K Luzuriaga, JL Sullivan, ... Nature medicine 6 (1), 76-81, 2000 | 519 | 2000 |
| Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial A Dorenbaum, CK Cunningham, RD Gelber, M Culnane, L Mofenson, ... Jama 288 (2), 189-198, 2002 | 507 | 2002 |
| Proposed definitions for in utero versus intrapartum transmission of HIV-1. YJ Bryson, K Luzuriaga, JL Sullivan, DW Wara | 497 | 1992 |
| High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection D Havlir, SH Cheeseman, M Mclaughlin, R Murphy, A Erice, SA Spector, ... Journal of Infectious Diseases 171 (3), 537-545, 1995 | 387 | 1995 |
| Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo D Hochberg, JM Middeldorp, M Catalina, JL Sullivan, K Luzuriaga, ... Proceedings of the National Academy of Sciences 101 (1), 239-244, 2004 | 380 | 2004 |
| ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. LA Pinto, J Sullivan, JA Berzofsky, M Clerici, HA Kessler, AL Landay, ... The Journal of clinical investigation 96 (2), 867-876, 1995 | 318 | 1995 |
| Frequency of'chronic active Epstein-Barr virus infection'in a general medical practice D Buchwald, JL Sullivan, AL Komaroff Jama 257 (17), 2303-2307, 1987 | 306 | 1987 |
| Deficient natural killer cell activity in X-linked lymphoproliferative syndrome JL Sullivan, KS Byron, FE Brewster, DT Purtilo Science 210 (4469), 543-545, 1980 | 292 | 1980 |
